✦ LIBER ✦

Health status (EuroQol-5 Dimension [EQ-5D]) in patients with painful diabetic peripheral neuropathy (DPN) treated with tapentadol extended release (ER): results of a randomized-withdrawal phase 3 study

✍ Scribed by Okamoto, A.; Shapiro, D.Y.; Lange, B.; Lange, R.; Etropolski, M.

Book ID: 123114989
Publisher: Canadian Diabetes Association
Year: 2009
Tongue: English
Weight: 435 KB
Volume: 33
Category: Article
ISSN: 1499-2671
DOI: 10.1016/S1499-2671(09)33157-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of tapentadol

Efficacy and tolerability of tapentadol extended release (ER) in patients with chronic, painful diabetic peripheral neuropathy (DPN): results of a phase 3, randomized-withdrawal, placebo-controlled study

✍ A. Vinik; D. Shapiro; C. Rauschkolb-Löffler; B. Lange; K. Karcher; D. Pennett; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Health-related outcomes associated with

✍ Etropolski, M.; Kleinert, R.; Shapiro, D.Y.; Okamoto, A.; Lange, R.; Rauschkolb, 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 436 KB

Sensitivity analyses of the primary effi

Sensitivity analyses of the primary efficacy endpoint in a randomized-withdrawal phase 3 trial of tapentadol extended release (ER) in patients with painful diabetic peripheral neuropathy (DPN)

✍ Etropolski, M.; Steup, A.; Shapiro, D.Y.; Okamoto, A.; Haeussler, J. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 448 KB

PMS4 EUROQOL-5 DIMENSION HEALTH STATUS Q

PMS4 EUROQOL-5 DIMENSION HEALTH STATUS QUESTIONNAIRE RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED PHASE 3 STUDY OF TAPENTADOL EXTENDED RELEASE (ER) FOR THE MANAGEMENT OF CHRONIC OSTEOARTHRITIS KNEE PAIN

✍ Kavanagh, S; Ashworth, J; Lange, B; Etropolski, MS; Van Hove, I; Rauschkolb, C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

333 SHORT FORM-36 (SF-36) AND EUROQOL-5

333 SHORT FORM-36 (SF-36) AND EUROQOL-5 DIMENSION (EQ-5D) RESULTS FROM RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDIES OF TAPENTADOL PROLONGED RELEASE (PR) IN PATIENTS WITH MODERATE TO SEVERE CHRONIC NOCICEPTIVE AND NEUROPATHIC PAIN

✍ R. Lange; B. Lange; A. Greene; A. Okamoto; M. Etropolski; J. Ashworth 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 265 KB